Effects of the β3-Adrenergic Receptor Agonist Disodium 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL-316243) on Bladder Micturition Reflex in Spontaneously Hypertensive Rats-Reference-Cited by-同舟云学术

Effects of the β3-Adrenergic Receptor Agonist Disodium 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL-316243) on Bladder Micturition Reflex in Spontaneously Hypertensive Rats

Published:2008-04-15 Issue:1 Volume:326 Page:178-185
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Leon Lisa A.,Hoffman Bryan E.,Gardner Scott D.,Laping Nicholas J.,Evans Christopher,Lashinger Erin S. R.,Su Xin

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference30 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international continence society

2. Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence

3. Efferent and afferent neuronal hypertrophy associated with micturition pathways in spontaneously hypertensive rats

4. ALTERED NGF REGULATION MAY LINK A GENETIC PREDISPOSITION FOR HYPERTENSION WITH HYPERACTIVE VOIDING

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary beta 3-adrenoceptor as a diagnostic biomarker for overactive bladder in women;Scientific Reports;2023-11-08

2. Updates of Overactive Bladder in Pediatrics;International Neurourology Journal;2023-03-31

3. Pharmacological Therapy;Benign Prostate Syndrome;2023

4. Comparative Efficacy of Different Drugs for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-03-07

5. How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies;Tzu Chi Medical Journal;2022